Anti-PD-1 for the treatment of advanced cutaneous squamous cell carcinoma in elderly patients: a French multicenter retrospective survey

BACKGROUND: Anti-PD1 agents are currently recommended as first-line treatment in advanced cutaneous squamous cell carcinoma (acSCC) by updated European guidelines. Although acSCC frequently affects elderly patients with multiple comorbidities, this subset of patients is often excluded of registratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Samaran, Quentin, Samaran, Romain, Ferreira, Ernestine, Haddad, Naeda, Fottorino, Antoine, Maillard, Hervé, Dreno, Brigitte, Meyer, Nicolas, Azria, David, Maubec, Eve, Gaudy-Marqueste, Caroline, Molinari, Nicolas, Stoebner, Pierre-Emmanuel, Dereure, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374288/
https://www.ncbi.nlm.nih.gov/pubmed/35962286
http://dx.doi.org/10.1007/s00432-022-04246-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374288/
https://www.ncbi.nlm.nih.gov/pubmed/35962286
http://dx.doi.org/10.1007/s00432-022-04246-0

Ejemplares similares